-
Je něco špatně v tomto záznamu ?
Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling
M. Babič, D. Horák, M. Trchová, P. Jendelová, K. Glogarová, P. Lesný, V. Herynek, M. Hájek, E. Syková
Jazyk angličtina Země Spojené státy americké
- MeSH
- adsorpce MeSH
- chemické jevy MeSH
- endocytóza účinky léků MeSH
- financování organizované MeSH
- fyzikální chemie MeSH
- krysa rodu rattus MeSH
- kultivační média MeSH
- kultivované buňky MeSH
- lidé MeSH
- lysin chemie MeSH
- magnetická rezonanční tomografie MeSH
- magnetismus MeSH
- mezenchymální kmenové buňky účinky léků ultrastruktura MeSH
- mikroskopie elektronová rastrovací MeSH
- molekulová hmotnost MeSH
- nanočástice MeSH
- oxid železnato-železitý MeSH
- oxidy chemie MeSH
- polylysin chemie MeSH
- proteiny MeSH
- spektroskopie infračervená s Fourierovou transformací MeSH
- transmisní elektronová mikroskopie MeSH
- transplantace kmenových buněk MeSH
- ultrazvuk MeSH
- velikost částic MeSH
- železité sloučeniny chemie MeSH
- železo chemie MeSH
- zvířata MeSH
- Check Tag
- krysa rodu rattus MeSH
- lidé MeSH
- zvířata MeSH
New surface-modified iron oxide nanoparticles were developed by precipitation of Fe(II) and Fe(III) salts with ammonium hydroxide and oxidation of the resulting magnetite with sodium hypochlorite, followed by the addition of poly( L-lysine) (PLL) solution. PLL of several molecular weights ranging from 146 ( L-lysine) to 579 000 was tested as a coating to boost the intracellular uptake of the nanoparticles. The nanoparticles were characterized by TEM, dynamic light scattering, FTIR, and ultrasonic spectrometry. TEM revealed that the particles were ca. 6 nm in diameter, while FTIR showed that their surfaces were well-coated with PLL. The interaction of PLL-modified iron oxide nanoparticles with DMEM culture medium was verified by UV-vis spectroscopy. Rat bone marrow stromal cells (rMSCs) and human mesenchymal stem cells (hMSC) were labeled with PLL-modified iron oxide nanoparticles or with Endorem (control). Optical microscopy and TEM confirmed the presence of PLL-modified iron oxide nanoparticles inside the cells. Cellular uptake was very high (more than 92%) for PLL-modified nanoparticles that were coated with PLL (molecular weight 388 00) at a concentration of 0.02 mg PLL per milliliter of colloid. The cellular uptake of PLL-modified iron oxide was facilitated by its interaction with the negatively charged cell surface and subsequent endosomolytic uptake. The relaxivity of rMSCs labeled with PLL-modified iron oxide and the amount of iron in the cells were determined. PLL-modified iron oxide-labeled rMSCs were imaged in vitro and in vivo after intracerebral grafting into the contralateral hemisphere of the adult rat brain. The implanted cells were visible on magnetic resonance (MR) images as a hypointense area at the injection site and in the lesion. In comparison with Endorem, nanoparticles modified with PLL of an optimum molecular weight demonstrated a higher efficiency of intracellular uptake by MSC cells.
- 000
- 04280naa 2200637 a 4500
- 001
- bmc10034910
- 003
- CZ-PrNML
- 005
- 20130129164331.0
- 008
- 101221s2008 xxu e eng||
- 009
- AR
- 040 __
- $a ABA008 $b cze $c ABA008 $d ABA008 $e AACR2
- 041 0_
- $a eng
- 044 __
- $a xxu
- 100 1_
- $a Babič, Michal $7 xx0109464
- 245 10
- $a Poly(L-lysine)-modified iron oxide nanoparticles for stem cell labeling / $c M. Babič, D. Horák, M. Trchová, P. Jendelová, K. Glogarová, P. Lesný, V. Herynek, M. Hájek, E. Syková
- 314 __
- $a Institute of Macromolecular Chemistry, v v i, Academy of Sciences of the Czech Republic, Heyrovsky Sq. 2, 162 06 Prague 6, Czech Republic
- 520 9_
- $a New surface-modified iron oxide nanoparticles were developed by precipitation of Fe(II) and Fe(III) salts with ammonium hydroxide and oxidation of the resulting magnetite with sodium hypochlorite, followed by the addition of poly( L-lysine) (PLL) solution. PLL of several molecular weights ranging from 146 ( L-lysine) to 579 000 was tested as a coating to boost the intracellular uptake of the nanoparticles. The nanoparticles were characterized by TEM, dynamic light scattering, FTIR, and ultrasonic spectrometry. TEM revealed that the particles were ca. 6 nm in diameter, while FTIR showed that their surfaces were well-coated with PLL. The interaction of PLL-modified iron oxide nanoparticles with DMEM culture medium was verified by UV-vis spectroscopy. Rat bone marrow stromal cells (rMSCs) and human mesenchymal stem cells (hMSC) were labeled with PLL-modified iron oxide nanoparticles or with Endorem (control). Optical microscopy and TEM confirmed the presence of PLL-modified iron oxide nanoparticles inside the cells. Cellular uptake was very high (more than 92%) for PLL-modified nanoparticles that were coated with PLL (molecular weight 388 00) at a concentration of 0.02 mg PLL per milliliter of colloid. The cellular uptake of PLL-modified iron oxide was facilitated by its interaction with the negatively charged cell surface and subsequent endosomolytic uptake. The relaxivity of rMSCs labeled with PLL-modified iron oxide and the amount of iron in the cells were determined. PLL-modified iron oxide-labeled rMSCs were imaged in vitro and in vivo after intracerebral grafting into the contralateral hemisphere of the adult rat brain. The implanted cells were visible on magnetic resonance (MR) images as a hypointense area at the injection site and in the lesion. In comparison with Endorem, nanoparticles modified with PLL of an optimum molecular weight demonstrated a higher efficiency of intracellular uptake by MSC cells.
- 650 _2
- $a adsorpce $7 D000327
- 650 _2
- $a zvířata $7 D000818
- 650 _2
- $a kultivované buňky $7 D002478
- 650 _2
- $a fyzikální chemie $7 D002627
- 650 _2
- $a kultivační média $7 D003470
- 650 _2
- $a endocytóza $x účinky léků $7 D004705
- 650 _2
- $a železité sloučeniny $x chemie $7 D005290
- 650 _2
- $a oxid železnato-železitý $7 D052203
- 650 _2
- $a lidé $7 D006801
- 650 _2
- $a železo $x chemie $7 D007501
- 650 _2
- $a lysin $x chemie $7 D008239
- 650 _2
- $a magnetická rezonanční tomografie $7 D008279
- 650 _2
- $a magnetismus $7 D008280
- 650 _2
- $a mezenchymální kmenové buňky $x účinky léků $x ultrastruktura $7 D059630
- 650 _2
- $a mikroskopie elektronová rastrovací $7 D008855
- 650 _2
- $a transmisní elektronová mikroskopie $7 D046529
- 650 _2
- $a molekulová hmotnost $7 D008970
- 650 _2
- $a nanočástice $7 D053758
- 650 _2
- $a oxidy $x chemie $7 D010087
- 650 _2
- $a velikost částic $7 D010316
- 650 _2
- $a chemické jevy $7 D055598
- 650 _2
- $a polylysin $x chemie $7 D011107
- 650 _2
- $a proteiny $7 D011506
- 650 _2
- $a krysa rodu Rattus $7 D051381
- 650 _2
- $a spektroskopie infračervená s Fourierovou transformací $7 D017550
- 650 _2
- $a transplantace kmenových buněk $7 D033581
- 650 _2
- $a ultrazvuk $7 D014465
- 650 _2
- $a financování organizované $7 D005381
- 700 1_
- $a Horák, Daniel $7 xx0076519
- 700 1_
- $a Trchová, Miroslava $7 xx0104474
- 700 1_
- $a Jendelová, Pavla, $d 1965- $7 xx0068971
- 700 1_
- $a Glogarová, Kateřina. $7 _AN033985
- 700 1_
- $a Lesný, Petr, $7 xx0060590 $d 1972-
- 700 1_
- $a Herynek, Vít, $d 1967- $7 xx0069420
- 700 1_
- $a Hájek, Milan, $d 1947- $7 xx0074172
- 700 1_
- $a Syková, Eva, $d 1944- $7 jn20000710633
- 773 0_
- $w MED00006454 $t Bioconjugate chemistry $g Roč. 19, č. 3 (2008), s. 740-750 $x 1043-1802
- 910 __
- $a ABA008 $b x $y 7
- 990 __
- $a 20110223123552 $b ABA008
- 991 __
- $a 20120817225256 $b ABA008
- 999 __
- $a ok $b bmc $g 823347 $s 688772
- BAS __
- $a 3
- BMC __
- $a 2008 $b 19 $c 3 $d 740-750 $i 1043-1802 $m Bioconjugate chemistry $n Bioconjug Chem $x MED00006454
- LZP __
- $a 2011-2B/ewme